New inhaled drug RB042 put to the test in healthy volunteers and smokers
NCT ID NCT07285122
First seen Jan 04, 2026 · Last updated May 19, 2026 · Updated 22 times
Summary
This early-stage study is testing whether an inhaled drug called RB042 is safe and how the body processes it. About 90 healthy adults and healthy smokers will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.